| BSE: 524540 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE930C01016 |
| BSE 00:00 | 04 Mar | Secunderabad Healthcare Ltd |
| NSE 05:30 | 01 Jan | Secunderabad Healthcare Ltd |
| OPEN | 6.17 |
| PREVIOUS CLOSE | 5.99 |
| VOLUME | 309707 |
| 52-Week high | 6.17 |
| 52-Week low | 0.00 |
| P/E | |
| Mkt Cap.(Rs cr) | 50 |
| Buy Price | 5.77 |
| Buy Qty | 25.00 |
| Sell Price | 6.10 |
| Sell Qty | 492.00 |
2.10 pm | 22 Feb 2019 | Press Trust of India
Shares of Dr Reddy's Laboratories were trading at Rs 2,640 per scrip on BSE, up 2.11 per cent from their previous close
9.50 am | 22 Feb 2019 | Business Standard
At 08:20 am, Nifty futures on the Singapore Exchange (SGX) were trading 19 points or 0.18 per cent lower at 10,794.50, indicating a tepid start for th...
11.14 pm | 21 Feb 2019 | Business Standard
Lack of significant launch visibility has led analysts to estimate net profit numbers to be little changed next year
4.08 pm | 21 Feb 2019 | Press Trust of India
The product is being recalled by Baltimore-based Lupin Pharmaceuticals Inc, a subsidiary of the company
3.57 pm | 21 Feb 2019 | Press Trust of India
Such recalls are for dangerous or defective products that predictably can cause serious health problems
1.54 pm | 21 Feb 2019 | Press Trust of India
In a regulatory filing, Piramal Enterprises said the apex court has ruled in favour of Saridon, which is a heritage brand from its healthcare product ...
6.35 am | 21 Feb 2019 | Business Standard
Nifty outlook and top trading ideas by Vaishali Parekh, research analyst - technical research at Prabhudas Lilladher.
12.21 am | 21 Feb 2019 | Business Standard
The potential revenue upside from the sale of generic Suboxone is expected to be substantial for Dr Reddy's when it resumes sales
12.37 am | 19 Feb 2019 | Business Standard
But US growth hinges on product approvals and pace of price erosion
2.41 pm | 18 Feb 2019 | Business Standard
The stock rallied 7% to Rs 828, its highest level since August 28, 2015, gaining 13% in the past one week, against 2.3% decline in the S&P BSE Sensex.
1.29 pm | 18 Feb 2019 | Press Trust of India
The company said its current portfolio consists of 150 products authorised for distribution in the US and 52 ANDA's pending approval with the USFDA
10.43 am | 18 Feb 2019 | Business Standard
The stock rose 5% to Rs 2,690 on the NSE in early morning trade in an otherwise weak market.
9.34 pm | 16 Feb 2019 | Business Standard
This is the second plant to come out of the warning letter after multiple inspections conducted by the US drug regulator
1.48 pm | 15 Feb 2019 | Business Standard
Bharat Forge, Godrej Agrovet, Natco Pharma and Tata Chemicals from the index hit their respective 52-week lows in intra-day trade on Friday.
1.48 pm | 15 Feb 2019 | Business Standard
Bharat Forge, Godrej Agrovet, Natco Pharma and Tata Chemicals from the index hit their respective 52-week lows in intra-day trade on Friday.
12.02 pm | 15 Feb 2019 | Business Standard
Dr Reddy's Laboratories had fallen 30 per cent to Rs 1,873 apiece earlier in the day, also its 52-week low on the NSE.
8.38 pm | 14 Feb 2019 | Press Trust of India
Glenmark's consolidated revenue stood at Rs 2,555.04 crore during the October-December 2018 period from Rs 2,203.66 crore in the year-ago period
9.03 am | 14 Feb 2019 | Business Standard
Here's a look at the top stocks that may remain in focus today -
2.12 am | 14 Feb 2019 | Business Standard
Govt had in September 2018 banned 344 FDC drugs, including Lupin's combo for diabetics, citing lack of therapeutic justification
3.24 pm | 13 Feb 2019 | Business Standard
The stock is locked in upper circuit of 20 per cent at Rs 588 on the BSE after the company reported an over six-fold jump in net profit at Rs 4.6 cror...
